MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Oromandibular Dystonia as an Initial Manifestation of Parkinson’s Disease: 2 Case Reports

F. Gao (San Francisco, CA, USA)

Meeting: 2019 International Congress

Abstract Number: 2155

Keywords: Orobuccolingual dyskinesia, Single-photon emission computed tomography(SPECT)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Phenomenology and Clinical Assessment of Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: We describe an unusual initial manifestation of Parkinson’s disease, consisting of oromandibular dystonia. We also discuss the role of DaTscan SPECT imaging in the diagnosis of uncommon presentations of Parkinson’s disease.

Background: Parkinson’s disease is a clinically heterogeneous disorder which typically features a combination of cardinal motor symptoms, classically rest tremor, bradykinesia, rigidity, and postural disturbances. However, patients can present with a broad range of symptoms that extend beyond these “classic” features.

Method: We describe 2 case reports seen recently at our institution. Neither patient had prior dopamine antagonist exposures.

Results: A 78 year old man presented for involuntary jaw opening, side-to-side movements of the tongue, and pharyngeal movements while speaking and swallowing for 9 years. He was previously treated with unsuccessful trials of trihexyphenidyl and tetrabenazine. His exam revealed subtle right hand rest tremor and bradykinesia. A DaTscan showed subtly decreased tracer uptake in the left putamen. We initiated him on levodopa, but he had no response to moderate-high dosages. Most recently, we treated him with botulinum toxin injections to the lateral pterygoids and genioglossus. A 71 year old woman presented for involuntary jaw opening and tongue movements for 6 years, which started after her lower teeth were extracted. The movements caused food to be expelled during chewing. Trials of botulinum toxin injection to the genioglossus, clonazepam, trihexyphenidyl, and amantadine were ineffective. Her symptoms slowly progressed and she also developed subtle right sided bradykinesia and rigidity. A DaTscan was performed, revealing decreased tracer uptake in the left putamen. She was started on low dose levodopa to which she has experienced a modest benefit.

Conclusion: Oromandibular dystonia is a rare form of focal dystonia, and can be either primary (idiopathic) or secondary, such as a tardive syndrome or resulting from certain dental cprocedures. However, Parkinson’s disease should be an important differential consideration, especially for an older patient with other asymmetric motor symptoms. In these clinical scenarios a DaTscan can be useful tool for differentiating parkinsonism from other etiologies, and is generally perceived as being clinically helpful for unusual or challenging clinical presentations.

To cite this abstract in AMA style:

F. Gao. Oromandibular Dystonia as an Initial Manifestation of Parkinson’s Disease: 2 Case Reports [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/oromandibular-dystonia-as-an-initial-manifestation-of-parkinsons-disease-2-case-reports/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/oromandibular-dystonia-as-an-initial-manifestation-of-parkinsons-disease-2-case-reports/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley